Glucagon for the management of hepatic emergencies

[1]  A. Baker.  Hepatotrophic factors: basic concepts and clinical implications. , 2009, Acta medica Scandinavica. Supplementum.

[2]  B. Balkau,et al.  Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial , 1992, Hepatology.

[3]  J. Koskinas,et al.  Insulin and glucagon infusion in acute alcoholic hepatitis: A prospective randomized controlled trial , 1991, Hepatology.

[4]  Y. Yamaoka,et al.  Effect of glucagon on hepatic energy charge and arterial ketone body ratio in normal rabbits. , 1991, Gastroenterology.

[5]  W. Meyers,et al.  Biliary response to glucagon and insulin following hepatic transplantation in humans. , 1990, The Journal of surgical research.

[6]  A. Forbes,et al.  Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure. , 1990, Journal of hepatology.

[7]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[8]  J. Emond,et al.  Liver transplantation in the management of fulminant hepatic failure. , 1989, Gastroenterology.

[9]  J. Mead,et al.  Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Moreau,et al.  Glucagon selectively increases splanchnic blood flow in patients with well‐compensated cirrhosis , 1988, Hepatology.

[11]  S. Poulsen,et al.  Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats , 1988, Hepatology.

[12]  J. Fischer,et al.  Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats. , 1988, Surgery.

[13]  J. Fischer,et al.  Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats. , 1988, The Journal of surgical research.

[14]  J. Poulos,et al.  Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. , 1988, The Journal of clinical investigation.

[15]  G I Bell,et al.  Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Abecassis,et al.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. , 1987, The Journal of clinical investigation.

[17]  Y. Chrétien,et al.  IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS? , 1987, The Lancet.

[18]  I. Rosenberg,et al.  Hepatic complications of total parenteral nutrition. , 1987, The American journal of medicine.

[19]  G. Kanel,et al.  Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. , 1982, Gastroenterology.

[20]  J. Schneider,et al.  A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients. , 1981, Gastroenterology.

[21]  H. Proctor,et al.  The effect of glucagon on hepatic cellular energetics during a low flow state. , 1980, Surgery.

[22]  H. Leffert,et al.  Hormonal control of rat liver regeneration. , 1979, Gastroenterology.

[23]  Allardyce Db,et al.  Cholestatic jaundice during total parenteral nutrition. , 1978 .

[24]  B. Lindberg,et al.  The effect of dextran 40 and blood transfusion on hepatic circulation and oxygen consumption in hemorrhagic shock. , 1977, The Journal of surgical research.

[25]  T. Starzl,et al.  EFFECTS OF INSULIN, GLUCAGON, AND INSULIN/GLUCAGON INFUSIONS ON LIVER MORPHOLOGY AND CELL DIVISION AFTER COMPLETE PORTACAVAL SHUNT IN DOGS , 1976, The Lancet.

[26]  J. B. Price,et al.  The role of factors of portal origin in modifying hepatic regeneration. , 1972, The Journal of surgical research.

[27]  T. Tsuji,et al.  The hepatocellular expression of a carbohydrate antigen ‘sialyl Lewis X’ in chronic hepatitis: A novel histological marker for active hepatic necroinflammation , 1990 .

[28]  J. Féher,et al.  A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis. , 1987, Journal of hepatology.

[29]  I. Rosenberg,et al.  Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease , 1985, Hepatology.

[30]  A. Moossa,et al.  Is glucagon a choleretic hormone at physiologic blood levels? , 1982, American journal of surgery.

[31]  N. Fukui,et al.  Prostaglandins as possible triggers for liver regeneration after partial hepatectomy. A review. , 1979, Cellular and molecular biology, including cyto-enzymology.

[32]  S. Cohen,et al.  Hormonal factors concerned with liver regeneration. , 1977, Ciba Foundation symposium.

[33]  N. Bucher,et al.  Hormonal factors and liver growth. , 1977, Advances in enzyme regulation.

[34]  F. W. Blaisdell,et al.  Effect of glucagon on total liver blood flow in hemorrhagic shock. , 1974, Acta chirurgica Scandinavica.